Content about president and CEO

November 6, 2012

Teva Pharmaceutical Industries has made a few new executive appointments, the drug maker said Tuesday.

November 5, 2012

Natural Products Solutions recently announced the launch of VirMax T Testosterone. As part of that launch, DSN caught up with NPS president and CEO Marty Gallant to discuss men’s health supplements. 


November 5, 2012

Pharmacy automation manufacturer Kirby Lester has launched a version of one of its tablet counters with streamlined verification software.

November 5, 2012

Improving medication adherence in specialty pharmacy could be equivalent to introducing a new blockbuster drug. That’s how Diplomat Specialty Pharmacy president and CEO Phil Hagerman put it at Drug Store News’ Specialty Pharmacy Roundtable two years ago. 


November 5, 2012

In what its president and CEO called a “significant milestone,” Watson Pharmaceuticals announced last month that the U.S. Federal Trade Commission and European Commission had approved its acquisition of Swiss generic drug maker Actavis.

November 1, 2012

AmerisourceBergen on Thursday reported revenue dropped 0.6% to $79.5 billion for its fiscal 2012 ended Sept. 30.

November 1, 2012

Lil’ Drug Store Products on Thursday announced the purchase of the Pre-Seed brand of feminine lubricant from BioOrigyn.

November 1, 2012

Nestlé on Tuesday named Luis Cantarell head of Nestlé Nutrition with the departure of Kurt Schmidt, deputy EVP Nestlé Nutrition, who has decided to leave the company for personal reasons effective Dec. 1.

November 1, 2012

Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said.

October 31, 2012

The Hain Celestial Group, a natural and organic products company, announced Monday the closing of the acquisition of Premier Food's portfolio of packaged grocery brands and its Histon manufacturing base in Cambridgeshire, United Kingdom.

October 31, 2012

Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.

October 29, 2012

AmerisourceBergen on Monday named Lawrence Marsh, 52, to the new role of chief strategy officer and SVP new market development, effective Nov. 12, 2012.

October 29, 2012

Ulta Beauty has announced that Michael MacDonald, president and CEO of DSW, a branded footwear and accessories retailer, has been appointed to its board.

October 26, 2012

In addition to an extensive structural makeover, dubbed the "Growth Game Plan", Newell Rubbermaid president and CEO Mike Polk announced a new leadership team that includes outside appointments to several executive positions.

October 25, 2012

The leader of pharmacy benefit manager Prime Therapeutics will be the keynote speaker at a specialty pharmacy conference Thursday.

October 23, 2012

New York’s hip and edgy beauty retailer Ricky’s NYC has tapped Catherine Moellering, former EVP at the retail consultancy Tobe Report, to serve as its new president and CEO, according to a published report.

October 18, 2012

CVS Caremark announced on Thursday the appointment of Alan Lotvin to the position of EVP specialty pharmacy.

October 11, 2012

Steve Mister, president and CEO for the Council for Responsible Nutrition, last week was named one of the year’s top CEOs by CEO Update, the publication that covers executive careers in associations, nonprofits and professional societies.

October 11, 2012

A coalition — which includes the California Medical Association, the California Dental Association, California Pharmacists Association, National Association of Chain Drug Stores, California Association of Medical Product Suppliers, AIDS Healthcare Foundation and American Medical Response — continues to work to block the state of California from cutting Medi-Cal reimbursement rates by 10%.

October 10, 2012

Nipro Diagnostics on Wednesday announced the introduction of a new portfolio of more than 30 ancillary products targeted to meet the needs of individuals with diabetes.

October 9, 2012

With healthcare reform on track to bring 32 million more Americans into the healthcare system in 2014, and with payers and patients looking for solutions to curb costs as the nation battles a shortage of primary care physicians and access to quality care, CVS Caremark’s role in reinventing pharmacy through its distinctive business model couldn’t be more imperative than it is today.


October 9, 2012

With its sights firmly fixed on delivering innovative solutions that address emerging customer needs that no stand-alone PBM or stand-alone retail pharmacy could provide, CVS Caremark is seeing growing interest in its proprietary programs — or integration sweet spots — known as Maintenance Choice and Pharmacy Advisor.


October 9, 2012

While CVS/pharmacy’s store clustering initiatives and store brands are fueling front-store profitability, there’s no doubt that its successful, long-standing ExtraCare loyalty program remains a key driver of front-store sales, and it arms the company with a powerful competitive advantage, especially as CVS looks to take the program to new heights. 


October 9, 2012

CVS Caremark’s front-store business continues to experience solid performance despite a weak economy — success that can be credited to such factors as a skilled merchandising team, a focus on store brands and a clustering initiative that tailors stores’ merchandise mix based on how the stores are shopped in certain locations.


© 2014 Drug Store News. All Rights Reserved.